Legence Sees Q3 Sales $1.225B-$1.275B vs $1.080B Est

Benzinga Newsdesk www.benzinga.com Positive 78.5%

Neg 0% Neu 0% Pos 78.5%

Legence (NASDAQ:LGN) sees Q3 sales of $1.225 billion-$1.275 billion vs $1.080 billion analyst estimate.

Comments

No comments yet. Be the first!